核酸样品製备市场：2025-2032年全球预测（依产品、工作流程类型、应用、最终使用者和自动化程度划分）

预计到 2032 年，核酸样品製备市场将成长至 100.2 亿美元，复合年增长率为 8.99%。

关键市场统计数据
基准年 2024	50.3亿美元
预计年份：2025年	54.7亿美元
预测年份 2032	100.2亿美元
复合年增长率 (%)	8.99%

了解核酸样本製备在实现可靠的分子工作流程和操作扩充性所发挥的策略作用

核酸样品製备生态系位于生命科学、临床诊断和工业生物技术的交会点，是分子工作流程中不可或缺的分析前基础。提取化学、自动化和整合仪器的进步，已使样品製备从一项常规的实验室任务发展成为实现高通量、高重复性和下游数据品质的关键策略基础。随着定序、基于PCR的诊断和高内涵筛检对核酸纯度和样品通量的需求不断增长，样品製备阶段的选择对检测灵敏度、週转时间和操作效率有显着的影响。

学术研究、临床实验室、法医部门和生物製药开发领域的相关人员正日益从可扩展性和合规性两个角度评估样本製备。这种转变反映了整个产业对快速诊断製备、可重复研究和经济高效的平台部署的普遍关注。因此，供应商和最终用户都在投资模组化仪器平台、经过验证的套件和标准化通讯协定，以减少变异性。由此可见，核酸样本製备的讨论并非一成不变，而是一个动态领域，其发展受到技术改进、不断变化的监管要求和不断扩展的应用领域的驱动，这些因素共同构成了采购、研发和临床部署等战略决策的背景。

自动化、化学和检验的工作流程的创新如何重新定义样品製备实践和供应商生态系统

近年来，核酸样本製备领域发生了翻天覆地的变化。技术创新与使用者需求的不断变化相互交融，重塑了供应商的策略和实验室的操作流程。自动化技术已从独立的机器人附加元件发展成为整合提取、纯化和品管步骤的平台，使实验室能够在不相应增加人工操作时间的情况下实现规模化生产。与硬体进步同步，化学技术的进步，例如改进的结合树脂和优化的裂解缓衝液，减少了抑製剂的使用，提高了产量的一致性，从而直接影响了下游检测的性能。

另一个重要变化是针对特定工作流程的试剂套件和检验的通讯协定的激增，这些方案均针对检体类型和法规环境量身定制。此趋势的驱动力源自于临床诊断对可重复性的需求，以及分散式检查环境中对即插即用解决方案的需求。此外，磁珠检测法在许多工作流程中逐渐成为标准方法，这促使人们重新评估耗材供应链，使用者要求试剂具有多供应商相容性和开放平台。这些变化正在建构一个更模组化和互通性的生态系统，在这个系统中，快速实施和通讯协定标准化与效能本身同等重要。

评估近期关税对样品製备价值链中仪器、试剂及製造地运作及供应链的影响

美国贸易政策在2025年推出的政策转变和关税措施，正为核酸样本製备领域的供应商和实验室客户带来微妙的营运压力。影响专用设备、进口试剂以及自动化萃取设备某些零件的关税，可能会增加到岸成本，并改变依赖全球供应链的实验室的筹资策略。为此，许多机构正在重新评估其采购基础，实现供应商多元化，并增加关键耗材的安全库存，以降低短期价格波动的风险。

除了采购环节，关税波动也可能加速在地化趋势，因为製造商需要权衡集中生产和本地生产之间的利弊，以保持成本竞争力。这会影响前置作业时间、品管和法规遵循性，尤其是在本地生产需要新的验证程序或修改试剂配方的情况下。重点，关税的累积影响也将波及利润微薄的合约研究和服务实验室。这些营业单位可能会将增加的成本转嫁给下游，或重新谈判服务合约以业务永续营运。总体而言，贸易政策趋势正在推动整个价值链的策略调整，其特点是供应多元化、在地化生产和重新评估库存管理实践。

分析产品、工作流程、应用、最终用户和自动化细分市场的趋势，以识别差异化的采用驱动因素和供应商定位机会。

从产品、工作流程类型、应用、最终用户和自动化等维度对市场进行分解，可以揭示供应商和买家面临的各种机会和挑战。产品细分涵盖仪器、套件、试剂和服务。仪器包括自动化萃取设备、离心机和真空歧管，可满足不同的通量和整合需求。套件包括DNA萃取试剂套件、RNA萃取试剂套件和病毒核酸萃取套件，这些试剂盒专为特定样品基质和监管要求而设计。试剂包括结合树脂、洗脱缓衝液、裂解缓衝液和洗涤缓衝液，这些试剂决定了纯度和产量特性。服务涵盖合约研究和客製化提取服务，为缺乏内部能力的机构提供灵活性。这些产品差异会影响采购决策、验证时间表和供应商选择标准。

工作流程细分进一步区分了DNA萃取、微生物萃取、质体萃取、RNA萃取和病毒核酸萃取的市场需求。每种工作流程都有方法特定的子类型，例如用于DNA和RNA提取的柱层析法、磁珠法和有机溶剂萃取方法，用于微生物提取的化学和机械裂解法，以及用于质体提取的碱性法和SDS法，这些子类型会影响耗材兼容性、自动化程度和检测灵敏度。应用主导的需求出现在临床诊断、药物发现与开发、法医分析、基因组学研究和个人化医疗等领域，每个领域对样品製备方案都有不同的监管、通量和品质要求。最终用户涵盖学术和临床实验室、法医和工业实验室、製药公司以及生物技术公司，预算週期、认证要求和通量预期影响着他们的采用模式。最后，自动化程度（全自动、手动或半自动）决定了资本投资和人事费用节约之间的平衡，进而影响整体拥有成本的考量，并影响实验室采用新平台的速度。

检验区域法规结构、采购行为和製造能力如何影响主要全球市场的采用趋势和供应商策略

区域趋势对核酸样本製备领域的筹资策略、监管合规性和创新采纳有显着影响。在美洲，对临床诊断整合、转化研究应用和高通量自动化的强劲需求显而易见，采购週期通常与健保报销政策和公共卫生优先事项一致。这为检验的套件和整合仪器平台的推广创造了有利环境，尤其是在可靠的技术支援和严格的监管文件相结合的情况下。区域内各国法规结构的差异也会影响诊断工作流程的采纳时间。

欧洲、中东和非洲地区（EMEA）市场格局复杂多元，欧洲部分地区的监管协调与整个地区的市场成熟度不一。该地区的买家优先考虑供应商支援、CE标誌或区域认证解决方案，以及能够应对跨境物流挑战的灵活供应安排。本地语言培训和特定语言的文檔通常会影响供应商的选择。亚太地区的特征是产能快速扩张、製造能力强大，以及市场接受度参差不齐，前沿学术机构与新兴临床市场并存。在这里，成本驱动型采购与积极采用自动化和本土试剂生产并存，迫使国际供应商调整其商业策略以适应当地的价格分布和伙伴关係模式。

透过平台互通性、检验的耗材、服务能力和永续性努力进行竞争差异化评估

核酸样本製备领域的竞争取决于技术差异化、耗材产品组合的广度以及提供端到端检验工作流程的能力。领先的仪器製造商透过平台间的互通性、处理能力的可扩展性以及能够减少临床和高通量研究客户停机时间的服务网络来脱颖而出。套件和试剂供应商则在与领先仪器的整合便捷性、对多种检体类型的应对力以及支援临床和研究应用案例的检验资料强度方面展开竞争。包括受託研究机构(CRO) 和客製化提取实验室在内的服务供应商，透过提供检验的流程和对特殊检体类型的快速回应来开闢市场。

仪器供应商和试剂开发商之间的策略联盟和交叉授权合约日益普遍，这加快了完整解决方案的上市速度，并缩短了实验室检验时间。此外，越来越多的公司加强对应用程式支援团队和培训专案的投入，以降低采用门槛，尤其对于那些从手动工作流程过渡到自动化工作流程的使用者而言。永续性方面的考量，例如减少塑胶废弃物和使用可回收耗材，正开始影响采购选择和产品开发蓝图，为竞争定位增添了新的维度。

为供应商和实验室管理人员提供加速采用、降低供应链风险以及使商业模式与客户工作流程保持一致的实用策略

透过推行目标明确、切实可行的倡议，产业领导者可以将不断变化的市场动态转化为策略优势。首先，优先考虑模组化平台设计和开放原始码互通性，可以增加可应用场景，缓解买家对供应商锁定的担忧，并扩大商业性覆盖范围。其次，投资检验的端到端工作流程和完善的技术文檔，可以加快客户采纳速度并缩短价值实现时间，这对临床实验室客户尤其重要。第三，实现製造地和采购管道多元化，可以降低关税带来的成本压力，同时提高应对供应中断的能力。

除了产品和供应层面，领导者还应透过弹性价格设定模式来强化其商业性提案。这些模式包括试剂租赁、按次付费模式以及符合客户营运预算的服务包。加强区域支援网络和本地化培训计划可以提高不同法规环境下的采用率，而与临床和学术机构建立有针对性的伙伴关係则可以产生高品质的检验数据并获得医疗服务提供者的认可。最后，将永续性目标纳入产品设计和耗材生命週期规划，可以使供应商凭藉前瞻性的采购政策脱颖而出，并帮助组织与机构的ESG目标保持一致。

本分析背后的调查方法采用了严格的混合方法研究通讯协定，结合了对医疗保健专业人员的访谈、技术文献、监管审查和交叉检验，以确保对该行业的深刻见解。

本分析所采用的研究途径结合了第一手资料和第二手资料，以确保对主题研究结果进行三角检验。第一手资料包括对临床实验室营运主管、学术机构采购负责人、受託研究机构技术总监以及仪器和试剂供应商产品经理的结构化访谈。这些访谈重点在于实际应用中的挑战、检验的考虑因素以及采购优先事项。第二手资料包括关于萃取化学的同行评审文献、与临床诊断相关的监管指导文件、记录创新轨蹟的专利申请以及仪器供应商的技术手册，以了解其整合能力。

定性分析的综合分析采用了交叉检验流程，具体而言，是将供应商的能力和相容性声明与独立使用者证言和监管文件进行交叉核对。此外，也参考了近期影响贸易和关税的公共变化，以阐明其对供应链的影响。在整个过程中，透过对主要受访者资料进行匿名化处理并对关键声明进行多重确认，有效控制了潜在的偏差，从而构建了一套观点实践经验的可靠证据体系，为本报告中提出的战略见解提供了有力支撑。

策略要务的整合：自动化、检验的耗材和可靠的采购管道共同提升了分子侦测效能。

核酸样品製备在分子生态系中扮演核心角色，萃取化学、自动化和检验工作流程的改进直接影响诊断灵敏度、研究可重复性和操作效率。这一格局将继续受到整合硬体、耗材和软体的技术融合平台以及受区域法规、关税环境和组织优先事项驱动的采购行为转变的影响。能够使其产品蓝图与客户在检验时间、供应可靠性和整体拥有成本方面面临的挑战相契合的供应商，将更有利于把握持续的需求。

实验室和企业负责人迫切需要平衡当前业务的连续性与对自动化、检验的耗材进行策略性投资，以支援未来的检测扩展。将供应商多元化纳入筹资策略、与供应商进行联合检验活动以及要求提供透明的技术论证，可以减少实施阻力并提高检测可靠性。透过共同采取这些措施，各机构可以最大限度地利用样品製备技术的进步，并将其转化为下游分子诊断结果的可衡量改进。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 开发一种基于磁性奈米粒子的核酸纯化方法，用于液态生物检体应用
• 利用机器人液体处理系统实现高通量样品製备工作流程自动化
• 推出用于就地检验的基于微流体晶片的核酸萃取技术
• 优化的直接PCR相容样品製备试剂套件，省略了传统的纯化步骤
• 用于转录组学的超低体积单细胞核酸分离方法的进展
• 将人工智慧驱动的品管分析整合到样品製备工作流程中
• 开发环境友善核酸萃取通讯协定，减少试剂用量
• 用于肿瘤研究的自动化FFPE组织核酸萃取套件的标准化
• 在核酸样品製备过程中引入数位化实验室资讯学和LIMS集成
• 一种能够同时萃取DNA和RNA的多重以微珠为基础纯化平台的出现

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 核酸样品製备市场（依产品分类）

• 装置
  • 自动提取装置
  • 离心机
  • 真空歧管
• 套件
  • DNA萃取试剂套件
  • RNA萃取试剂套件
  • 病毒核酸萃取套件
• 试剂
  • 黏合树脂
  • 洗脱缓衝液
  • 裂解缓衝液
  • 洗涤缓衝液
• 服务
  • 合约研究
  • 客製化提取服务

9. 依工作流程类型分類的核酸样品製备市场

• DNA萃取
  • 基于列
  • 以微珠为基础的
  • 有机萃取
• 微生物萃取
  • 化学溶解
  • 机械溶解
• 质体萃取
  • 碱性溶解
  • 基于SDS
• RNA萃取
  • 基于列
  • 以微珠为基础的
  • 有机萃取
• 病毒核酸萃取
  • 基于列
  • 以微珠为基础的

第十章 依应用分類的核酸样品製备市场

• 临床诊断
• 药物发现与开发
• 法医学分析
• 基因组研究
• 个人化医疗

第十一章 核酸样品製备市场（依最终用户划分）

• 学术研究机构
• 临床实验室
• 法医科学研究所
• 工业研究院
• 製药和生物技术公司

12. 核酸样品製备市场依自动化程度划分

• 全自动
• 手动的
• 半自动

13. 各地区核酸样品製备市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十四章 核酸样品製备市场（依组别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十五章 各国核酸样品製备市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十六章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • Thermo Fisher Scientific Inc.
  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Promega Corporation
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Takara Bio Inc.
  • New England Biolabs, Inc.

The Nucleic Acid Sample Preparation Market is projected to grow by USD 10.02 billion at a CAGR of 8.99% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 5.03 billion
Estimated Year [2025]	USD 5.47 billion
Forecast Year [2032]	USD 10.02 billion
CAGR (%)	8.99%

Understanding the strategic role of nucleic acid sample preparation in enabling reliable molecular workflows and operational scalability

The nucleic acid sample preparation ecosystem sits at the intersection of life sciences, clinical diagnostics, and industrial biotechnology, serving as the essential pre-analytical backbone for molecular workflows. Advances in extraction chemistry, automation, and integrated instruments have elevated sample prep from a routine laboratory task to a strategic enabler of throughput, reproducibility, and downstream data quality. As sequencing, PCR-based diagnostics, and high-content screening continue to demand purer nucleic acids and higher sample throughput, the choices made at the sample preparation stage materially influence assay sensitivity, turnaround time, and operational efficiency.

Stakeholders across academic research, clinical labs, forensic units, and biopharma development are increasingly evaluating sample preparation through the twin lenses of scalability and compliance. This shift reflects broader industry priorities including rapid diagnostic readiness, reproducible research, and cost-effective platform deployment. Consequently, vendors and end users alike are investing in modular instrument platforms, validated kits, and standardized protocols that reduce variability. The narrative of nucleic acid sample preparation is therefore not static; it is a dynamic field driven by technological refinement, evolving regulatory expectations, and expanding application domains that together set the context for strategic decisions in procurement, R&D, and clinical deployment.

How innovations in automation, chemistry, and validated workflows are redefining sample preparation practices and vendor ecosystems

Recent years have seen transformative shifts across the nucleic acid sample preparation landscape, where technological innovation and changing user demands converge to reshape vendor strategies and laboratory practices. Automation has moved beyond single-use robotic add-ons to integrated platforms that combine extraction, purification, and quality control steps, enabling laboratories to scale without proportionate increases in hands-on time. Parallel to hardware evolution, chemistry improvements such as enhanced binding resins and optimized lysis buffers have reduced inhibitory substances and improved yield consistency, directly impacting downstream assay performance.

Another important shift is the proliferation of workflow-specific kits and validated protocols tailored to sample types and regulatory environments. This trend has been driven by the need for reproducibility in clinical diagnostics and the demand for plug-and-play solutions in decentralized testing environments. Additionally, the rise of magnetic bead-based methods as a default for many workflows has prompted a reassessment of consumable supply chains, with users seeking multi-vendor compatibility and open-platform reagents. Taken together, these changes are creating a more modular, interoperable ecosystem where rapid deployment and protocol standardization are prioritized alongside raw performance.

Assessing the operational and supply chain ramifications of recent tariff actions on instruments, reagents, and manufacturing footprints within the sample preparation value chain

Policy shifts and tariff measures introduced in 2025 within United States trade policy have introduced nuanced operational pressures for suppliers and laboratory customers involved in nucleic acid sample preparation. Tariffs that affect specialized instruments, imported reagents, and certain components used in automated extractors have the potential to increase landed costs and alter sourcing strategies for laboratories that rely on global supply chains. In response, many organizations are reassessing their procurement footprints, exploring diversified supplier panels, and increasing safety stock for critical consumables to mitigate near-term volatility.

Beyond procurement, tariff-related changes can accelerate regionalization trends as manufacturers evaluate the trade-offs between centralized production and localized manufacturing to preserve cost competitiveness. This has implications for lead times, quality control frameworks, and regulatory compliance, particularly where local production requires new validation steps or changes in reagent formulations. Importantly, the cumulative impact of tariffs extends to contract research providers and service laboratories that operate on thin margins; these entities may pass increased costs downstream or renegotiate service contracts to maintain viability. In sum, trade policy developments are prompting a strategic recalibration across the value chain, characterized by supply diversification, manufacturing localization, and revised inventory management practices.

Parsing product, workflow, application, end user, and automation segment dynamics to reveal differentiated adoption drivers and vendor positioning opportunities

Deconstructing the market along product, workflow type, application, end user, and automation axes reveals nuanced opportunities and constraints for vendors and buyers alike. Product segmentation spans instruments, kits, reagents, and services, where instruments encompass automated extractors, centrifuges, and vacuum manifolds that address different throughput and integration needs; kits include DNA extraction kits, RNA extraction kits, and viral nucleic acid extraction kits designed for specific sample matrices and regulatory demands; reagents consist of binding resins, elution buffers, lysis buffers, and wash buffers that determine purity and yield characteristics; and services cover contract research and custom extraction services that provide flexibility for organizations without in-house capacity. These product distinctions inform purchasing decisions, validation timelines, and vendor selection criteria.

Workflow segmentation further differentiates market needs across DNA extraction, microbial extraction, plasmid extraction, RNA extraction, and viral nucleic acid extraction. Each workflow contains method-specific subtypes-such as column-based, magnetic bead-based, and organic extraction for DNA and RNA; chemical lysis and mechanical lysis for microbial extraction; and alkaline lysis or SDS-based methods for plasmid extraction-that influence consumable compatibility, automation potential, and assay sensitivity. Application-driven demand emerges across clinical diagnostics, drug discovery and development, forensic analysis, genomic research, and personalized medicine, each placing distinct regulatory, throughput, and quality requirements on sample prep choices. End users range from academic research laboratories and clinical laboratories to forensic and industrial labs, as well as pharmaceutical and biotechnology companies, with adoption patterns shaped by budget cycles, accreditation needs, and throughput expectations. Finally, automation tiers-fully automated, manual, and semi-automated-define the balance between capital expenditure and labor savings, shaping total cost of ownership considerations and influencing the pace at which labs adopt new platforms.

Examining how regional regulatory frameworks, procurement behaviors, and manufacturing capacity shape adoption and vendor strategy across major global markets

Regional dynamics significantly influence procurement strategies, regulatory compliance, and innovation adoption within the nucleic acid sample preparation space. The Americas demonstrate a strong emphasis on clinical diagnostics integration, translational research applications, and an appetite for high-throughput automation, with procurement cycles often tied to reimbursement policies and public health priorities. This creates an environment where validated kits and integrated instrument platforms gain traction, especially when coupled with reliable technical support and rigorous regulatory documentation. Comparative regulatory frameworks across countries within the region also affect time-to-deployment for diagnostic workflows.

Europe, Middle East & Africa present a heterogeneous landscape where regulatory harmonization in parts of Europe coexists with variable market maturity across the Middle East and Africa. Buyers in this region prioritize vendor support, CE-marked or regionally certified solutions, and flexible supply arrangements that account for cross-border logistics challenges. Localized training and language-specific documentation frequently influence vendor selection. The Asia-Pacific region is characterized by rapid capacity expansion, strong manufacturing capabilities, and a mixed adoption curve where cutting-edge academic centers coexist with emerging clinical markets. Here, cost-sensitive procurement coexists with aggressive adoption of automation and domestic reagent production, prompting international vendors to adapt commercial strategies to local price points and partnership models.

Evaluating competitive differentiation through platform interoperability, validated consumables, service capabilities, and sustainability commitments

Competitive dynamics in nucleic acid sample preparation are influenced by a combination of technological differentiation, breadth of consumable portfolios, and the ability to provide end-to-end validated workflows. Leading instrument manufacturers differentiate through platform interoperability, throughput scaling, and service networks that reduce downtime for clinical and high-throughput research customers. Kit and reagent suppliers compete on ease of integration with popular instruments, robustness across sample types, and the strength of validation data supporting clinical or research use cases. Service providers, including contract research organizations and custom extraction labs, carve niches by offering validated pipelines and rapid turnaround times for specialized sample types.

Strategic partnerships and cross-licensing arrangements between instrument vendors and reagent developers are frequent, enabling faster market entry for complete solutions and helping laboratories shorten validation timelines. Additionally, an increasing number of companies are investing in application support teams and training programs to reduce adoption friction, particularly for buyers transitioning from manual to automated workflows. Sustainability considerations, such as reduced plastic waste and recyclable consumables, are beginning to influence procurement choices and product development roadmaps, adding an additional dimension to competitive positioning.

Actionable strategies for vendors and laboratory leaders to accelerate adoption, de-risk supply chains, and align commercial models with customer workflows

Industry leaders can convert shifting market dynamics into strategic advantage by pursuing a set of focused, actionable initiatives. First, prioritizing modular platform design and open-source interoperability increases addressable use cases and reduces buyer reluctance around vendor lock-in, thereby expanding commercial reach. Second, investing in validated end-to-end workflows and robust technical documentation accelerates customer onboarding and shortens time-to-value, which is particularly important for clinical laboratory customers. Third, diversifying manufacturing and sourcing footprints mitigates exposure to tariff-driven cost pressures while improving resilience against disruption.

Beyond product and supply considerations, leaders should enhance commercial propositions through flexible pricing models, including reagent leasing, pay-per-test arrangements, and bundled service offerings that align with customers' operational budgets. Strengthening regional support networks and localized training initiatives will improve adoption rates in diverse regulatory environments, while targeted partnerships with clinical and academic centers can generate high-quality validation data and practitioner advocacy. Finally, embedding sustainability targets into product design and consumable lifecycle planning can differentiate vendors with forward-looking procurement mandates and help organizations align with institutional ESG objectives.

A rigorous mixed-methods research protocol combining practitioner interviews, technical literature, regulatory review, and cross-validation to ensure robust industry insights

The research approach underpinning this analysis combined primary and secondary methods to ensure triangulation and validation of thematic findings. Primary inputs included structured interviews with operational leaders in clinical laboratories, procurement managers at academic institutions, technical directors at contract research providers, and product managers at instrument and reagent suppliers. These engagements focused on real-world adoption challenges, validation considerations, and procurement priorities. Secondary inputs comprised peer-reviewed literature on extraction chemistries, regulatory guidance documents relevant to clinical diagnostics, patent filings that highlight innovation trajectories, and technical manuals from instrument vendors to understand integration capabilities.

Qualitative synthesis was complemented by cross-validation steps, where vendor claims about throughput and compatibility were contrasted against independent user testimony and regulatory documentation. Attention was paid to recent public policy changes affecting trade and tariffs to contextualize supply chain implications. Throughout the process, potential biases were managed by anonymizing primary respondent data and seeking multiple confirmations for critical assertions, resulting in a robust, practitioner-focused body of evidence that supports the strategic insights presented in this report.

Synthesizing strategic imperatives where automation, validated consumables, and resilient sourcing converge to enhance molecular assay performance

Nucleic acid sample preparation occupies a pivotal role in the molecular ecosystem, where improvements in extraction chemistry, automation, and validated workflows directly influence diagnostic sensitivity, research reproducibility, and operational throughput. The landscape will continue to be shaped by technological convergence-platforms that integrate hardware, consumables, and software-alongside shifting procurement behaviors driven by regional regulations, tariff environments, and institutional priorities. Vendors that align product roadmaps with customer pain points such as validation time, supply reliability, and total cost of ownership will be best positioned to capture durable demand.

For laboratories and corporate buyers, the imperative is to balance near-term operational resilience with strategic investments in automation and validated consumables that support future assay expansion. Building supplier diversity into sourcing strategies, engaging in collaborative validation exercises with vendors, and demanding transparent technical evidence will reduce deployment friction and enhance assay reliability. Taken together, these steps will enable organizations to harness the full potential of advances in sample preparation and translate them into measurable improvements in downstream molecular outcomes.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Development of magnetic nanoparticle-based nucleic acid purification for liquid biopsy applications
• 5.2. Automation of high-throughput sample preparation workflows with robotic liquid handlers
• 5.3. Implementation of microfluidic chip-based nucleic acid extraction for point-of-care testing
• 5.4. Optimization of direct-to-PCR sample preparation kits eliminating traditional purification steps
• 5.5. Advancements in ultra low-input single-cell nucleic acid isolation methods for transcriptomics
• 5.6. Integration of artificial intelligence-driven quality control analytics in sample prep workflows
• 5.7. Development of environmentally friendly and reagent-reduced nucleic acid extraction protocols
• 5.8. Standardization of automated FFPE tissue nucleic acid co-extraction kits for oncology research
• 5.9. Adoption of digital lab informatics and LIMS integration in nucleic acid sample preparation processes
• 5.10. Emergence of multiplexed bead-based purification platforms for simultaneous DNA and RNA extraction

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nucleic Acid Sample Preparation Market, by Product

• 8.1. Instruments
  • 8.1.1. Automated Extractors
  • 8.1.2. Centrifuges
  • 8.1.3. Vacuum Manifolds
• 8.2. Kits
  • 8.2.1. Dna Extraction Kits
  • 8.2.2. Rna Extraction Kits
  • 8.2.3. Viral Nucleic Acid Extraction Kits
• 8.3. Reagents
  • 8.3.1. Binding Resins
  • 8.3.2. Elution Buffers
  • 8.3.3. Lysis Buffers
  • 8.3.4. Wash Buffers
• 8.4. Services
  • 8.4.1. Contract Research
  • 8.4.2. Custom Extraction Services

9. Nucleic Acid Sample Preparation Market, by Workflow Type

• 9.1. Dna Extraction
  • 9.1.1. Column Based
  • 9.1.2. Magnetic Bead Based
  • 9.1.3. Organic Extraction
• 9.2. Microbial Extraction
  • 9.2.1. Chemical Lysis
  • 9.2.2. Mechanical Lysis
• 9.3. Plasmid Extraction
  • 9.3.1. Alkaline Lysis
  • 9.3.2. Sds Based
• 9.4. Rna Extraction
  • 9.4.1. Column Based
  • 9.4.2. Magnetic Bead Based
  • 9.4.3. Organic Extraction
• 9.5. Viral Nucleic Acid Extraction
  • 9.5.1. Column Based
  • 9.5.2. Magnetic Bead Based

10. Nucleic Acid Sample Preparation Market, by Application

• 10.1. Clinical Diagnostics
• 10.2. Drug Discovery And Development
• 10.3. Forensic Analysis
• 10.4. Genomic Research
• 10.5. Personalized Medicine

11. Nucleic Acid Sample Preparation Market, by End User

• 11.1. Academic Research Laboratories
• 11.2. Clinical Laboratories
• 11.3. Forensic Laboratories
• 11.4. Industrial Laboratories
• 11.5. Pharmaceutical And Biotechnology Companies

12. Nucleic Acid Sample Preparation Market, by Automation

• 12.1. Fully Automated
• 12.2. Manual
• 12.3. Semi Automated

13. Nucleic Acid Sample Preparation Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Nucleic Acid Sample Preparation Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Nucleic Acid Sample Preparation Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Analysis
  • 16.3.1. Thermo Fisher Scientific Inc.
  • 16.3.2. QIAGEN N.V.
  • 16.3.3. F. Hoffmann-La Roche Ltd.
  • 16.3.4. Merck KGaA
  • 16.3.5. Bio-Rad Laboratories, Inc.
  • 16.3.6. Promega Corporation
  • 16.3.7. Agilent Technologies, Inc.
  • 16.3.8. Illumina, Inc.
  • 16.3.9. Takara Bio Inc.
  • 16.3.10. New England Biolabs, Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. AMERICAS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. NORTH AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. LATIN AMERICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. EUROPE NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. MIDDLE EAST NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. AFRICA NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. ASEAN NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. GCC NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. EUROPEAN UNION NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. BRICS NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. G7 NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. NATO NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. NUCLEIC ACID SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 30. NUCLEIC ACID SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. NUCLEIC ACID SAMPLE PREPARATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED EXTRACTORS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VACUUM MANIFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION KITS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION KITS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION KITS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY BINDING RESINS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ELUTION BUFFERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY LYSIS BUFFERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WASH BUFFERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY REGION, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY REGION, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CONTRACT RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CUSTOM EXTRACTION SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW TYPE, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DNA EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MICROBIAL EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CHEMICAL LYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL LYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PLASMID EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ALKALINE LYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY SDS BASED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 183. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 184. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 185. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 186. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY RNA EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 187. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 188. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 189. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 190. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 191. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 192. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 193. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 194. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 195. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 196. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 197. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 198. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 199. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 200. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 201. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 202. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 203. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 204. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ORGANIC EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 205. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, 2018-2024 (USD MILLION)
• TABLE 206. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, 2025-2032 (USD MILLION)
• TABLE 207. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 208. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 209. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 210. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 211. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 212. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY VIRAL NUCLEIC ACID EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 213. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 214. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 215. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 216. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 217. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 218. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 219. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 220. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 221. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 222. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 223. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 224. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC BEAD BASED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 225. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 226. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 227. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 228. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 229. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 230. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 231. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 232. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 233. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 234. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 235. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 236. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 237. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 238. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 239. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 240. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 241. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 242. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 243. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 244. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 245. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
• TABLE 246. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY REGION, 2025-2032 (USD MILLION)
• TABLE 247. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 248. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 249. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 250. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY GENOMIC RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 251. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 252. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 253. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 254. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 255. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 256. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 257. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 258. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 259. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 260. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 261. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 262. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 263. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 264. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 265. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 266. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 267. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 268. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 269. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 270. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 271. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 272. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 273. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 274. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 275. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 276. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY FORENSIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 277. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INDUSTRIAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 278. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET SIZE, BY INDUSTRIAL LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 279. GLOBAL NUCLEIC ACID SAMPLE PREPARATION MARKET